logo

For the Inventor, By the Inventor

Piscataway, NJ, United States of America

Kevin Matthew Maloney

This inventor holds 12 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Merck Canada Inc., Werthenstein Biopharma Gmbh. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Matthew Maloney. Retrieved from https://idiyas.com/inventor/kevin-matthew-maloney

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 100.0

 

Average Co-Inventor Count = 11.7

ph-index = 6

Forward Citations = 68(Granted Patents)


Location History:

  • Piscataway, NJ (US) (2014 - 2023)
  • Metuchen, NJ (US) (2023)

Company Filing History:

goldMedal12 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal1 out of 40 
 
Merck Canada Inc.
 patents
bronzeMedal1 out of 2 
 
Werthenstein Biopharma Gmbh
 patents
where one patent can have more than one assignee

Years Active: 2014-2023

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 11767292 - Process for making beta 3 agonists and intermediates (2023-09-26),
2. 11708371 - Process for making beta 3 agonists and intermediates (2023-07-25),
3. 11584724 - Process for synthesis of a phenoxy diaminopyrimidine compound (2023-02-21),
4. 11542279 - Solid forms of ceftolozane and processes for preparing (2023-01-03),
5. 11124478 - Process for making beta 3 agonists and intermediates (2021-09-21),
6. 10899771 - Process for making beta 3 agonists and intermediates (2021-01-26),
7. 10577316 - Process for making beta 3 agonists and intermediates (2020-03-03),
8. 10435410 - Process for making beta 3 agonists and intermediates (2019-10-08),
9. 10087189 - Process for making beta 3 agonists and intermediates (2018-10-02),
10. 9822121 - Process for making beta 3 agonists and intermediates (2017-11-21),
11. 9809536 - Process for making beta 3 agonists and intermediates (2017-11-07),
12. 8674093 - Process for the preparation of an orexin receptor antagonist (2014-03-18),

Title: The Innovative Journey of Kevin Matthew Maloney

Introduction:

Kevin Matthew Maloney, a talented inventor hailing from Piscataway, NJ, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

Kevin Matthew Maloney holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices, showcasing his diverse expertise and inventive spirit.

Career Highlights:

Throughout his illustrious career, Kevin Matthew Maloney has worked with leading tech companies to develop cutting-edge solutions that have revolutionized industries and improved the lives of many. His commitment to innovation and problem-solving is evident in the numerous successful projects he has spearheaded.

Collaborations:

Kevin Matthew Maloney has collaborated with top researchers, engineers, and scientists to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the creation of innovative products that have received acclaim in the tech community.

Conclusion:

In conclusion, Kevin Matthew Maloney stands as a beacon of innovation in the technological landscape, with a proven track record of turning visionary ideas into reality. His relentless pursuit of excellence and passion for pushing the boundaries of what is possible continue to inspire aspiring inventors worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…